articleAnnals of OncologyMay 9, 2008Closed access

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

BCBruno ChauffertFMF. MornexFBF. BonnetainPRP. RougierCMC. Mariette

Centre Georges François Leclerc · Hôpital Lyon Sud · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

693
total citations
FWCI
16.06
Percentile
100%
References
30
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • Gemcitabine
  • Medicine
  • Cisplatin
  • Chemoradiotherapy
  • Oncology
  • Pancreatic cancer
  • Phases of clinical research
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.